Research Article

Potential Diagnostic and Prognostic Biomarkers of Circular RNAs for Lung Cancer in China

Table 3

The results of the diagnostic analysis.

First authorSensitivitySpecificityLR+ (95%CI)LR- (95%CI)DORAUC

Li JP0.76 (0.66-0.84)0.72 (0.68-0.84)2.69 (1.91-3.80)0.33 (0.23-0.49)8.08 (4.18-15.63)
Zhang YN0.80 (0.65-0.90)0.73 (0.58-0.85)3.00 (1.81-4.98)0.27 (0.15-0.50)11.00 (4.11-29.45)
Zhang SY0.87 (0.74-0.95)0.85 (0.71-0.94)5.71 (2.86-11.41)0.15 (0.07-0.33)37.14 (11.46-120.42)
Zhu XL0.76 (0.61-0.87)0.80 (0.66-0.90)3.70 (2.08-6.58)0.31 (0.18-0.51)12.02 (4.64-31.16)
Zong L0.81( 0.68-0.90)0.89 (0.78-0.96)7.67 (3.56-16.52)0.22 (0.13-0.37)35.55 (12.17-103.79)
Pooled0.80 (0.74-0.84)0.80 (0.73-0.86)3.97 (2.80-5.62)0.26 (0.19-0.34)15.51 (8.76-27.47)0.85 (0.82-0.88)
I2054.09%17.25%12.03%93.33%

LR+: positive likelihood ratios; LR–, negative likelihood ratios; DOR, diagnostic odds ratios; AUC, area under curve; I2, inconsistency index.